Jennifer Pietenpol

Members of the Vanderbilt University Medical Center (VUMC) community and others whose lives and careers have been influenced by legendary cancer investigator, educator and administrator Harold (Hal) Moses, M.D., have endowed the Linda and Harold L. Moses, M.D. Career Development Fund. Read More

On the same day 48 years after the July 20, 1969, Apollo 11 moon landing, individuals from throughout the Vanderbilt community reflected on that historic event — a milestone marking the ultimate synthesis of innovative thinking and technology — as they shared their own explorations and mission moments during StrategyShare17. Read More

Nearly 400 members of the Canby Robinson Society and the Vanderbilt University Medical Center (VUMC) community joined together at Cheekwood Estate and Gardens recently for a reception celebrating the Medical Center’s shared commitment to healthy communities and to pioneer the future of health care. Read More

Jennifer Pietenpol, Ph.D., Executive Vice President for Research at Vanderbilt University Medical Center (VUMC) and director of Vanderbilt-Ingram Cancer Center (VICC), has been named a Chief Scientific Advisor (CSA) for the nonprofit breast cancer organization Susan G. Komen. Read More

Communication and collaboration were major themes of the inaugural Research Enterprise Forum sponsored jointly by Vanderbilt University Medical Center (VUMC) and Vanderbilt University School of Medicine (VUSM) Feb. 3 in Light Hall. Read More

The 2017 class of Chancellor Faculty Fellows comprises highly accomplished, recently tenured faculty from across the university. Read More

Douglas Lowy, M.D., acting director of the National Cancer Institute (NCI), warned that worldwide death rates from cervical cancer are expected to increase in low- and middle-income countries during the next 15 years unless steps are taken to prevent the cancer from occurring. Almost all cases of cervical cancer are linked to a viral infection. Read More

The health of people around the world depends to a large extent on the ability of the global health community to predict what challenges must be met in the future. Read More

Nearly 39,000 new cancers associated with the human papillomavirus (HPV) will be diagnosed in the United States this year. Although HPV vaccines can prevent the majority of these cancers, vaccination rates remain low across the country. Read More

Members of the Vanderbilt community are mourning the loss of music executive and health care philanthropist Tony Martell, who died Sunday, Nov. 27, at his home in New Jersey. He was 90. Read More

Nominations are now being accepted for the 2017 cohort of Chancellor Faculty Fellows, Provost and Vice Chancellor for Academic Affairs Susan R. Wente announced today. Read More

As part of the national Cancer Moonshot initiative, a Blue Ribbon Panel (BRP) of cancer leaders, including four from Vanderbilt-Ingram Cancer Center, has delivered a series of recommendations to accelerate the pace of cancer prevention efforts and scientific discovery. Read More

Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers. Read More

With the transition of Vanderbilt University Medical Center (VUMC) into a new financial and legal entity now complete, Medical Center leaders view this period as an opportunity to sharpen the organization’s strategic focus. Read More

The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment. Read More

Jennifer Pietenpol, Ph.D., director of the Vanderbilt-Ingram Cancer Center, B.F. Byrd Jr. Professor of Molecular Oncology and Professor of Biochemistry, Cancer Biology and Otolaryngology, has been named Executive Vice President for Research at Vanderbilt University Medical Center (VUMC). Her appointment is effective May 1. Read More

Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center (VICC), has been selected to serve on a Blue Ribbon Panel that will inform the scientific direction and goals at the National Cancer Institute (NCI) for Vice President Joe Biden’s National Cancer Moonshot Initiative. Read More

The p73 gene is required for the generation of cilia – hair-like projections on cells – findings that could have implications for the study of lung diseases and sterility. Read More

Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center (VICC), was honored with the Medical Research Advancement Award during the 8th Annual T.J. Martell Foundation Nashville Honors Gala held recently at the Omni Nashville Hotel. Read More

For more than twenty years, Vanderbilt-Ingram Cancer Center’s (VICC) primary source of outside funding has been provided by the National Institutes of Health. But in breast cancer, Susan G. Komen, a nonprofit dedicated to breast cancer research and community services, has been a significant sponsor of research and patient care support. Read More